MDCX SCHEDULE 13D/A: SEC filing

Filed with the SEC on · accession 0000950142-26-003112

MDCX filed a SCHEDULE 13D/A (schedule 13d/a) with the SEC on Nov 17, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -10.1% by the first close after the filing.

Summary of the filing

Dr. Raza Bokhari and his controlled entity RBx Capital, LP acquired 436,046 common shares of Medicus Pharma Ltd. in a private placement at $1.72 per share for approximately $750,000, increasing their combined beneficial ownership to 19.1%.

Key details

Aggregate purchase price for 436,046 private placement shares at $1.72 per share$750K
Purchase price per common share$2
IssuerMedicus Pharma Ltd.
Acquirer / reporting person controlled by dr. raza bokhariRBx Capital, LP
Reporting person / managing partner of rbx capital, lpRaza Bokhari

How MDCX stock reacted

Close before

$1.69

Nov 16, 2026

First close after

-10.06%

$1.52

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for MDCX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for MDCX?

Click here

Frequently asked questions

What did MDCX file with the SEC on Nov 17, 2026?

MDCX filed a SCHEDULE 13D/A (SEC filing). Dr. Raza Bokhari and his controlled entity RBx Capital, LP acquired 436,046 common shares of Medicus Pharma Ltd. in a private placement at $1.72 per share for approximately $750,000, increasing their combined beneficial ownership to 19.1%.

How do I read a SCHEDULE 13D/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13D/A (schedule 13d/a): A report the company filed with the SEC (the US market regulator).

How did MDCX stock react to this filing?

MDCX closed at $1.69 before the filing and $1.52 on Nov 17, 2026 (-10.06%).

Other MDCX SEC filings

Get alerts when MDCX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days